| Characteristic | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
| Age at diagnosis | 20–29 | 1.00 | 1.00 | 30–39 | 0.70 (0.63, 0.78) | 0.68 (0.60, 0.76) | ≥40 | 0.18 (0.11, 0.30) | 0.22 (0.13, 0.37) |
| One-year period before assumed fertility date | TCM nonusers | 1.00 | 1.00 | TCM users | 1.50 (1.35, 1.68) | 1.48 (1.31, 1.66) |
| Number of outpatient visits | 0 | 1.00 | 1.00✝ | 1–3 | 1.25 (1.09, 1.43) | 1.22 (1.05, 1.41) | >3 | 1.74 (1.53, 1.98) | 1.73 (1.50, 1.98) |
| Number of days for drug prescription | 0 | 1.00 | 1.00✝ | 1–14 | 1.30 (1.12, 1.51) | 1.25 (1.07, 1.47) | >14 | 1.76 (1.55, 1.99) | 1.73 (1.51, 1.97) |
| Insured amount (NT$/month) | <20,000 | 1.00 | 1.00 | 20,000–39,999 | 1.11 (0.98, 1.26) | 1.06 (0.92, 1.23) | 40,000–59,999 | 1.43 (1.22, 1.68) | 1.33 (1.10, 1.62) | ≥60,000 | 1.59 (1.26, 2.00) | 1.76 (1.35, 2.30) |
| Urban level | 1 | 1.00 | 1.00 | 2 | 0.89 (0.78, 1.02) | 0.87 (0.74, 1.02) | 3 | 1.08 (0.92, 1.27) | 1.09 (0.90, 1.33) | ≥4 | 0.92 (0.78, 1.08) | 0.98 (0.79, 1.21) |
| Residential area | Taipei | 1.00 | 1.00 | Northern | 0.96 (0.81, 1.13) | 1.02 (0.84, 1.24) | Central | 0.92 (0.78, 1.07) | 0.88 (0.72, 1.07) | Southern | 0.98 (0.82, 1.16) | 1.06 (0.86, 1.32) | Eastern | 1.01 (0.65, 1.59) | 0.81 (0.49, 1.34) | Kao-Ping | 0.92 (0.78, 1.09) | 0.99 (0.82, 1.20) |
| Insured unit | Government, school employees | 1.00 | 1.00 | Private enterprise employees | 0.72 (0.61, 0.86) | 0.77 (0.63, 0.94) | Member of occupational | 0.58 (0.46, 0.73) | 0.75 (0.58, 0.98) | Farmers, fishermen | 0.57 (0.42, 0.77) | 0.69 (0.49, 0.98) | Low-income households veterans, other regionals | 0.49 (0.39, 0.62) | 0.59 (0.44, 0.78) |
| Comorbidities | Hypertension | 0.48 (0.25, 0.93) | 0.84 (0.41, 1.73) | Diabetes | 0.35 (0.19, 0.64) | 0.43 (0.22, 0.84) | Hypercholesterolemia | 0.59 (0.33, 1.05) | 0.90 (0.48, 1.70) | Obesity | 0.50 (0.23, 1.07) | 0.71 (0.31, 1.59) | Cerebral vascular disease | 0.75 (0.26, 2.17) | 0.61 (0.19, 1.96) | COPD | 0.96 (0.76, 1.23) | 0.93 (0.71, 1.20) | Renal failure | 0.50 (0.13, 2.00) | 0.61 (0.13, 2.81) | Tobacco use | 0.50 (0.05, 5.52) | 0.65 (0.06, 7.46) | Anemia | 0.77 (0.41, 1.46) | 0.70 (0.36, 1.38) | Polycystic ovary syndrome | 1.00 (0.76, 1.32) | 0.97 (0.72, 1.32) | Endometriosis | 0.72 (0.57, 0.91) | 0.88 (0.68, 1.14) | Irregular menstrual cycle | 0.97 (0.86, 1.08) | 0.91 (0.81, 1.04) | Uterine fibroids | 0.65 (0.49, 0.86) | 0.86 (0.63, 1.17) | Dysmenorrhea | 0.79 (0.65, 0.95) | 0.75 (0.61, 0.93) |
| Fertility drugs | Clomiphene citrate/tamoxifen | 3.87 (3.37, 4.44) | 3.53 (3.06, 4.08) | GnRH agonist/GnRH antagonist | — | — | Progesterone | 3.34 (2.54, 4.39) | 2.53 (1.89, 3.38) | Bromocriptine/cabergoline | 3.06 (2.10, 4.46) | 2.20 (1.48, 3.27) |
|
|